Get started
Author

Bernd Blank

Observed name: B. Blank
Observed institutions: Olgahospital, Klinikum Stuttgart
OpenAlex ID: A5074367227
Desmoplastic small round cell tumors: Multimodality treatment and new risk factors
2019 · Monika Scheer, Christian Vokuhl, et al. · Cancer Medicine · 60
PDF
PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2014 · Verena Thalhammer, Laura A. Lopez-Garcia, et al. · Cancer Research · 50
PDF
The prognostic impact of SYT‐SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trials
2016 · Sabine Stegmaier, Ivo Leuschner, et al. · Pediatric Blood & Cancer · 42
Synovial Sarcoma Recurrence in Children and Young Adults
2016 · On behalf of the Cooperative Weichteilsarkom Studiengruppe [CWS], Monika Scheer, et al. · Annals of Surgical Oncology · 42
Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol
2022 · Ewa Koscielniak, Bernd Blank, et al. · Cancers · 32
PDF
Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
2020 · Monika Scheer, Bernd Blank, et al. · Journal of Cancer Research and Clinical Oncology · 19
Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry
2023 · Ewa Koscielniak, Beate Timmermann, et al. · Journal of Clinical Oncology · 16
Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS‐81, ‐86, ‐91, ‐96, and ‐2002P trials
2019 · Guido Seitz, Cristian Urla, et al. · Pediatric Blood & Cancer · 16
Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial
2024 · Ewa Koscielniak, Gustaf Ljungman, et al. · EClinicalMedicine · 14
Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS‐81, ‐86, ‐91, ‐96, and ‐2002P trials
2018 · Guido Seitz, Cristian Urla, et al. · Pediatric Blood & Cancer · 13
Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS
2025 · Ewa Koscielniak, Sabine Stegmaier, et al. · Cancer Medicine · 12
PDF
Reduced artefacts and improved assessment of hyperintense brain lesions with BLADE MR imaging in patients with neurofibromatosis type 1
2009 · Thekla von Kalle, Bernd Blank, et al. · Pediatric Radiology · 10
Metronomic oral maintenance chemotherapy in patients with localized high-risk rhabdomyosarcoma (RMS) and RMS-like tumors: A report from a randomized, multicenter, phase III trial CWS-2007HR.
2022 · Ewa Koscielniak, Monika Sparber-Sauer, et al. · Journal of Clinical Oncology · 5
Supplementary Figure Legends from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
PDF
Data from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Supplementary Table S3 from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Supplementary Table S1 from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Supplementary Table S2 from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Supplementary Materials and Methods from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Supplementary Figures S1-S7 from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Supplementary Table S3 from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
2023 · Verena Thalhammer, Laura A. Lopez-Garcia, et al.
Prognosis of Children and Adolescents with Soft Tissue Ewing Tumors (STET) Treated in 3 Consecutive, Prospective Studies of the Cooperative Weichsteilsarkom Studiengruppe (CWS)
2014 · E. Koscielniak, Tobias M. Dantonello, et al. · Pediatric Blood & Cancer
1.o.06 Is Institution a Prognostic Factor in Adolescent and Young Adult Patients With Osteosarcoma
2010 · D. Carrle, Bernd Blank, et al. · Orthopaedic Proceedings
4105 Is institution a prognostic factor in adolescent and young adult patients with osteosarcoma?b
2009 · D. Carrle, B. Blank, et al. · European Journal of Cancer Supplements
Works count: 24
Citation count: 331
H-index: 11
I10-index: 12
Year
Topic
Type